[Federal Register Volume 65, Number 146 (Friday, July 28, 2000)]
[Notices]
[Page 46482]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-19133]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel ``Clinical Centers for the Clinical Network 
for the Treatment of the Adult Respiratory Distress Syndrome 
(ARDS)''.
    Date: August 1, 2000.
    Time: 8 am to 5 pm.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, II Rockledge Center, 6701 
Rockledge Drive, Room 7214, Bethesda, MD 20892-7924 (Telephone 
Conference Call).
    Contact Person: C. James Scheirer, PhD, Chief, Review Branch, 
Division of Extramural Affairs, National Heart, Lung, and Blood 
Institute, Rockledge Center II, 6701 Rockledge Drive, Suite 7216, 
Bethesda, MD 20892-7924, 301-435-0266.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: July 20, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-19133 Filed 7-27-00; 8:45 am]
BILLING CODE 4140-01-M